124 related articles for article (PubMed ID: 32809160)
1. Evaluation of pleural lesions after pleurodesis with OK-432 by fluorodeoxyglucose-positron emission tomography/CT.
Nishimori M; Yoshimatsu R; Iwasa H; Miyatake K; Nitta N; Anayama T; Yamagami T
Ann Nucl Med; 2020 Oct; 34(10):793-798. PubMed ID: 32809160
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
Kwek BH; Aquino SL; Fischman AJ
Chest; 2004 Jun; 125(6):2356-60. PubMed ID: 15189963
[TBL] [Abstract][Full Text] [Related]
3. Histology of the pleural rind at [
Soltermann A; Opitz I; Burger IA
Pathol Res Pract; 2021 Dec; 228():153660. PubMed ID: 34749212
[TBL] [Abstract][Full Text] [Related]
4. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
5. Intense pleural FDG uptake 12 years after talc pleurodesis: PET/CT findings.
Gorospe Sarasúa L; Jover-Díaz R; Arrieta P
Arch Bronconeumol; 2017 Nov; 53(11):638. PubMed ID: 28554586
[No Abstract] [Full Text] [Related]
6. Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.
Kitajima K; Nakamichi T; Hasegawa S; Kuribayashi K; Yamakado K
Cureus; 2018 Nov; 10(11):e3654. PubMed ID: 30723653
[TBL] [Abstract][Full Text] [Related]
7. Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma.
Vandemoortele T; Laroumagne S; Roca E; Bylicki O; Dales JP; Dutau H; Astoul P
Respiration; 2014; 87(3):243-8. PubMed ID: 24457915
[TBL] [Abstract][Full Text] [Related]
8. Changes in the pleural cavity by pleurodesis using talc or OK-432: an experimental study.
Muta F; Takamori S; Matsuo T; Iwasaki Y; Yoshiyama K; Shirouzu K
Surg Today; 2011 Jan; 41(1):111-4. PubMed ID: 21191701
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive role of [
Zucali PA; Lopci E; Ceresoli GL; Giordano L; Perrino M; Ciocia G; Gianoncelli L; Lorenzi E; Simonelli M; De Vincenzo F; Setti LR; Bonifacio C; Bonomi M; Bombardieri E; Chiti A; Santoro A
Cancer Med; 2017 Oct; 6(10):2287-2296. PubMed ID: 28941158
[TBL] [Abstract][Full Text] [Related]
10. The utility of 18F-FDG PET/CT in solitary fibrous tumors of the pleura.
Tazeler Z; Tan G; Aslan A; Tan S
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):165-70. PubMed ID: 26632105
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
Nguyen NC; Tran I; Hueser CN; Oliver D; Farghaly HR; Osman MM
Clin Nucl Med; 2009 Dec; 34(12):886-90. PubMed ID: 20139823
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
13. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
Sun Y; Yu H; Ma J; Lu P
PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
15. False positive 18F-FDG-PET/CT in a patient after talc pleurodesis.
Ahmadzadehfar H; Palmedo H; Strunk H; Biersack HJ; Habibi E; Ezziddin S
Lung Cancer; 2007 Dec; 58(3):418-21. PubMed ID: 17624474
[TBL] [Abstract][Full Text] [Related]
16. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
17. Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography.
Weiss N; Solomon SB
Clin Nucl Med; 2003 Oct; 28(10):811-4. PubMed ID: 14508271
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
19. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
